436506 A Novel Low-Volume Two-Chamber Microfabricated Platform for Evaluating Drug Metabolism and Toxicity (Rapid Fire)

Wednesday, November 11, 2015
Exhibit Hall 1 (Salt Palace Convention Center)
Shyam Sundhar Bale1, Gautham V. Sridharan1, Rohit Jindal1 and Martin L. Yarmush1,2, (1)Center for Engineering in Medicine (CEM) at Massachusetts General Hospital Harvard Medical School - Shriners Hospital for Children, Boston, MA, (2)Biomedical Engineering, Rutgers University, Piscataway, NJ

To evaluate drug and metabolite efficacy on a target organ, it is essential to include metabolic function of hepatocytes, and to evaluate metabolite influence on both hepatocytes and the target of interest. Herein, we have developed a two-chamber microfabricated device separated by a membrane enabling communication between hepatocytes and cancer cells. The microscale environment created enables cell co-culture in a low media-to-cell ratio leading to higher metabolite formation and rapid accumulation, which is lost in traditional plate cultures or other interconnected models due to higher culture volumes. We demonstrate the efficacy of this system by metabolism of tegafur by hepatocytes resulting in cancer cell toxicity.

Extended Abstract: File Not Uploaded
See more of this Session: Poster Session: Bioengineering
See more of this Group/Topical: Food, Pharmaceutical & Bioengineering Division